Research and Development

The Research and Development team at Sotio is responsible for advancing innovative immunotherapy treatments by conducting preclinical and clinical research. This team collaborates to design and execute experiments, assess safety and efficacy, and translate findings into viable therapeutic options aimed at improving outcomes for cancer patients. Their expertise spans across discovery research, translational science, and pharmacology to support the development of cutting-edge dendritic cell therapies.